Bradley J. Turner

9.7k citations

95 papers · 4.0k indexed · h-index 36

Neurology top 0.5%
Molecular Biology top 5%
Genetics top 0.5%
Cellular and Molecular Neuroscience top 5%
Physiology top 5%

Co-authors: Kevin Talbot Nirma D. Perera Julie D. Atkin Surindar S. Cheema Elizabeth C. Lopes Andrew F. Hill Justin J. Yerbury Malcolm Horne
Topics: Amyotrophic Lateral Sclerosis Research (58 papers)Neurogenetic and Muscular Disorders Research (40 papers)Parkinson's Disease Mechanisms and Treatments (18 papers)
Cited by: Neurology Genetics
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Nature Communications
Partner nations: Australia United States United Kingdom

In The Last Decade

Bradley J. Turner

92 papers receiving 3.9k citations

Peers

Countries citing papers authored by Bradley J. Turner

Since Specialization

Citations

This map shows the geographic impact of Bradley J. Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley J. Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley J. Turner more than expected).

Fields of papers citing papers by Bradley J. Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bradley J. Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley J. Turner. The network helps show where Bradley J. Turner may publish in the future.

Co-authorship network of co-authors of Bradley J. Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Bradley J. Turner. A scholar is included among the top collaborators of Bradley J. Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bradley J. Turner. Bradley J. Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cortical hyperexcitability drives dying forward amyotrophic lateral sclerosis symptoms and pathology in mice 2025 ·Progress in Neurobiology ·Mouna Haidar,(unknown),(unknown),(unknown),(unknown),(unknown),Doris Tomas,Samuel A. Mills,(unknown),Elvan Djouma,Nirma D. Perera,Sophia J. Luikinga,(unknown),Samantha K. Barton,David G. Gonsalvez,Lucy M. Palmer,Catriona McLean,(unknown),Steve Vucic,Bradley J. Turner	0
2	The Amyotrophic Lateral Sclerosis M114T PFN1 Mutation Deregulates Alternative Autophagy Pathways and Mitochondrial Homeostasis 2022 ·International Journal of Molecular Sciences ·Elisa Teyssou,(unknown),Delphine Roussel,Nirma D. Perera,Ivan Nemazanyy,Dominique Langui,Mélanie Albert,(unknown),(unknown),François Salachas,Pierre‐François Pradat,Vincent Meininger,Philippe Ravassard,Francine Côté,Christian S. Lobsiger,Séverine Boillée,Bradley J. Turner,Danielle Seilhean,Stéphanie Millecamps	12
3	Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS 2021 ·Neuroscience Letters ·Steve Vucic,Nathan Pavey,Mouna Haidar,Bradley J. Turner,Matthew C. Kiernan	32
4	The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice 2020 ·Purinergic Signalling ·(unknown),(unknown),(unknown),(unknown),Nicholas J. Geraghty,(unknown),(unknown),Bradley J. Turner,Debbie Watson,Justin J. Yerbury,Ronald Sluyter	26
5	Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS 2019 ·Cell Death and Differentiation ·(unknown),Nirma D. Perera,(unknown),(unknown),(unknown),Doris Tomas,André L. Samson,Wayne Cawthorne,(unknown),James M. Murphy,Bradley J. Turner	59
6	Transactive Response DNA-Binding Protein 43 Abnormalities after Traumatic Brain Injury 2018 ·Journal of Neurotrauma ·Xin Tan,Mujun Sun,Rhys D. Brady,Shijie Liu,Roxana M. Llanos,(unknown),David Wright,Pablo M. Casillas‐Espinosa,Maithili Sashindranath,Terence J. O’Brien,Stuart J. McDonald,Bradley J. Turner,Sandy R. Shultz	24
7	Disease Mechanisms in ALS: Misfolded SOD1 Transferred Through Exosome-Dependent and Exosome-Independent Pathways 2016 ·Cellular and Molecular Neurobiology ·Judith M. Silverman,(unknown),Leslie I. Grad,Andrew F. Hill,Bradley J. Turner,Justin J. Yerbury,Neil R. Cashman	79
8	Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice 2016 ·Human Molecular Genetics ·Nirma D. Perera,Rebecca K. Sheean,Peter J. Crouch,Anthony R. White,Malcolm Horne,Bradley J. Turner	19
9	Diverse Roles for Wnt7a in Ventral Midbrain Neurogenesis and Dopaminergic Axon Morphogenesis 2014 ·Stem Cells and Development ·(unknown),Julianna Kele,Christopher R. Bye,Jonathan C. Niclis,Walaa F. Alsanie,Brette Blakely,Jan M. Stenman,Bradley J. Turner,Clare L. Parish	25
10	The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass 2013 ·The Journal of Cell Biology ·Catherine E. Winbanks,Justin L. Chen,Hongwei Qian,Yingying Liu,Bianca C. Bernardo,Claudia Beyer,Kevin I. Watt,Rachel E. Thomson,Timothy Connor,Bradley J. Turner,Julie R. McMullen,Lars Larsson,Sean L. McGee,Craig A. Harrison,Paul Gregorevic	168
11	Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice 2013 ·Neurobiology of Aging ·Bradley J. Turner,Neza Alfazema,Rebecca K. Sheean,James N. Sleigh,Kay E. Davies,Malcolm Horne,Kevin Talbot	35
12	Motor neuron diseases : causes, classification, and treatments 2012 ·Bradley J. Turner,Julie D. Atkin	2
13	HspB8 mutation causing hereditary distal motor neuropathy impairs lysosomal delivery of autophagosomes 2011 ·Journal of Neurochemistry ·(unknown),Kanchan Phadwal,Bradley J. Turner,Peter L. Oliver,(unknown),Anna Katharina Simon,Kevin Talbot,Vishwas R. Agashe	47
14	Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model 2009 ·Neurobiology of Disease ·Bradley J. Turner,Nick Parkinson,Kay E. Davies,Kevin Talbot	56
15	TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy 2008 ·BMC Neuroscience ·Bradley J. Turner,Dirk Bäumer,Nick Parkinson,Jakub Scaber,Olaf Ansorge,Kevin Talbot	53
16	Impaired Extracellular Secretion of Mutant Superoxide Dismutase 1 Associates with Neurotoxicity in Familial Amyotrophic Lateral Sclerosis 2005 ·Journal of Neuroscience ·Bradley J. Turner,Julie D. Atkin,Manal A. Farg,(unknown),Alan Rembach,Elizabeth C. Lopes,(unknown),Andrew F. Hill,Surindar S. Cheema	154
17	The β‐amyloid peptide of Alzheimer's disease decreases adhesion of vascular smooth muscle cells to the basement membrane 2005 ·Journal of Neurochemistry ·Su San Mok,Dušan Lošić,Colin J. Barrow,Bradley J. Turner,Colin L. Masters,Lisandra L. Martin,David H. Small	30
18	Chemotherapy Delays Progression of Motor Neuron Disease in the SOD1 G93A Transgenic Mouse 2004 ·Chemotherapy ·(unknown),Kailash Narayan,Hui Kong,(unknown),Elizabeth C. Lopes,Bradley J. Turner,John F. Bertram,Surindar S. Cheema	5
19	Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS 2004 ·Journal of Neuroscience Research ·Alan Rembach,Bradley J. Turner,Stephen J. Bruce,Irwin K. Cheah,Rachel Scott,Elizabeth C. Lopes,(unknown),Philip M. Beart,Nam Sang Cheung,Steven J. Langford,Surindar S. Cheema	57
20	Antisense peptide nucleic acid‐mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice 2003 ·Journal of Neurochemistry ·Bradley J. Turner,Irwin K. Cheah,(unknown),Elizabeth C. Lopes,Steven Petratos,Steven J. Langford,Surindar S. Cheema	79

About Bradley J. Turner

Bradley J. Turner is a scholar working on Neurology, Genetics and Neurology, having authored 95 papers that have together received 4.0k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (58 papers), Neurogenetic and Muscular Disorders Research (40 papers) and Parkinson's Disease Mechanisms and Treatments (18 papers). The work is most often cited by research in Neurology (1.9k citations), Genetics (1.2k citations) and Neurology (529 citations). Bradley J. Turner has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Kevin Talbot, Nirma D. Perera, Julie D. Atkin, Surindar S. Cheema, Elizabeth C. Lopes, Andrew F. Hill, Justin J. Yerbury, Malcolm Horne, Manal A. Farg and Neil R. Cashman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact